NMTC News and Press, NeuroOne Medical Technologies Corporation From 11/19/21

NeuroOne is a developer of flexible, minimally invasive, thin film electrodes for cEEG and sEEG recording, and the diagnosis and treatment of neurological conditions. Mayo Clinic is a key development partner and shareholder, and Zimmer Biomet is a strategic development and marketing p...

Gainers: Jasper (NASDAQ:JSPR) +127%. Waitr Holdings (NASDAQ:WTRH) +55%. Clarus Therapeutics Holdings (NASDAQ:CRXT) +46%. Sono-Tek (NASDAQ:SOTK) +26%. Paltalk (NASDAQ:PALT) +21%. Statera Biopharma (NASDAQ:STAB) +20%. SMART Global Holdings (NASDAQ:SGH) +15%. NeuroBo Pharmaceuticals (NASDAQ:NRBO...

Gainers: Jasper Therapeutics JSPR +114%, Clarus Therapeutics (NASDAQ:CRXT) +45%, Alimera Sciences ALIM +19%, Revance Therapeutics RVNC +13%, Recursion Pharmaceuticals (NASDAQ:RXRX) +12%. Losers: NeuroOne Medical Technologies NMTC -25%, Ne...

NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock PR Newswire EDEN PRAIRIE, Minn. , Oct. 13, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the "Company"), a medical technology comp...

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock PR Newswire EDEN PRAIRIE, Minn. , Oct. 12, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the "Company"), a medical technology compan...

NeuroOne® Medical Technologies Corporation Announces Successful Completion of Feasibility Study for Ablation Electrode Company's combination recording and ablation technology is the next intended product in its technology pipeline PR Newswire EDEN PRAIRIE, Min...

NeuroOne to Present at H.C. Wainwright 23rd Annual Global Investment Conference PR Newswire EDEN PRAIRIE, Minn. , Sept. 9, 2021 /PRNewswire/ -- NeuroOne ® Medical Technologies Corporation (Nasdaq: NMTC) (NeuroOne or the Company), a medical techno...

NeuroOne® Medical Technologies Corporation Receives FDA 510(k) Clearance for its Evo® sEEG Electrode Company's second FDA 510(k) clearance received PR Newswire EDEN PRAIRIE, Minn. , Sept. 7, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Co...

Gainers: ZIOPHARM Oncology (NASDAQ:ZIOP) +39%, RenovoRx (NASDAQ:RNXT) +17%, Sigilon Therapeutics (NASDAQ:SGTX) +17%, Acumen Pharmaceuticals (NASDAQ:ABOS) +15%, NeuroOne Medical Technologies (NASDAQ:NMTC) +7%. Losers: CorMedix (NASDAQ:CRMD) -25...

Gainers: Cellect Biotechnology (NASDAQ:APOP) +39%. NeuroOne Medical Technologies (NASDAQ:NMTC) +17%. Enveric Biosciences (NASDAQ:ENVB) +16%. Impel NeuroPharma (NASDAQ:IMPL) +12%. Progenity (NASDAQ:PROG) +10%. Losers: Forte Biosciences (NASDAQ:FBRX) -81%. Evelo Biosciences (NASDAQ:EV...